Unexpectedly catapulted into global fame as a COVID-19 vaccine maker, BioNTech is on the verge of returning to its oncology ...
Building on recent successes, scientists are focused on a promising new frontier: sending tiny particles into the body to ...
Ramaswamy's biotech firm is collecting $950 million from Moderna for the same COVID vaccine technology he now attacks as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results